Picture of Seegene logo

096530 Seegene Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareSpeculativeMid CapHigh Flyer

Annual cashflow statement for Seegene, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line537,561182,432733-20,27048,445
Depreciation
Amortisation
Non-Cash Items171,159157,46615,81235,3531,299
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-410,606-78,83312,676-86229,581
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities334,024319,00994,93285,391149,334
Capital Expenditures-66,112-72,452-31,879-43,626-40,466
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-36,561-31,528-246,44778,295-92,707
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-102,673-103,980-278,32734,669-133,173
Financing Cash Flow Items-1,834-1,407-1,0000
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-110,302-144,501-156,700-63,705-64,006
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash124,00689,216-331,00769,356-34,125